Ayhan A - Search Results

1

SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.

Kahramanoglu I, Meydanli MM, Taranenka S, Ayhan A, Salman C, Sanci M, Demirkiran F, Ortac F, Haidopoulos D, Sukhin V, Kaidarova D, Stepanyan A, Farazaneh F, Aliyev S, Ulrikh E, Kurdiani D, Yalcin İ, Mavrichev S, Akilli H, Sarı ME, Pletnev A, Aslan K, Bese T, Kairbayev M, Vlachos D, Gultekin M. Kahramanoglu I, et al. Among authors: ayhan a. Int J Gynecol Cancer. 2019 Oct;29(8):1271-1279. doi: 10.1136/ijgc-2019-000643. Epub 2019 Sep 2. Int J Gynecol Cancer. 2019. PMID: 31481453

2

Endometrial carcinoma: a pathologic evaluation of 142 cases with and without associated endometrial hyperplasia.

Ayhan A, Yarali H, Ayhan A. Ayhan A, et al. J Surg Oncol. 1991 Mar;46(3):182-4. doi: 10.1002/jso.2930460312. J Surg Oncol. 1991. PMID: 2011030

3

Stage I adenocarcinoma of the uterine cervix: tumour size, grade, lymph node metastases and 5-year survival.

Ayhan A, Yüce K, Tuncer ZS, Urman B, Ayhan A. Ayhan A, et al. Aust N Z J Obstet Gynaecol. 1989 Nov;29(4):443-4. doi: 10.1111/j.1479-828x.1989.tb01786.x. Aust N Z J Obstet Gynaecol. 1989. PMID: 2631680

4

Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases.

Ayhan A, Tuncer ZS, Tuncer R, Yüce K, Küçükali T. Ayhan A, et al. Eur J Obstet Gynecol Reprod Biol. 1994 Dec;57(3):167-70. doi: 10.1016/0028-2243(94)90294-1. Eur J Obstet Gynecol Reprod Biol. 1994. PMID: 7713290

5

Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance.

Ayhan A, Tok EC, Bildirici I, Ayhan A. Ayhan A, et al. Gynecol Oncol. 2001 Mar;80(3):355-8. doi: 10.1006/gyno.2000.6014. Gynecol Oncol. 2001. PMID: 11263931

6

Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases).

Ayhan A, Tuncer R, Tuncer ZS, Yüce K, Küçükali T. Ayhan A, et al. Int J Gynecol Cancer. 1994 Sep;4(5):306-309. doi: 10.1046/j.1525-1438.1994.04050306.x. Int J Gynecol Cancer. 1994. PMID: 11578422

7

Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?

Ayhan A, Taskiran C, Celik C, Guney I, Yuce K, Ozyar E, Atahan L, Kucukali T. Ayhan A, et al. Gynecol Oncol. 2002 Sep;86(3):259-63. doi: 10.1006/gyno.2002.6630. Gynecol Oncol. 2002. PMID: 12217745

8

The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.

Ayhan A, Taskiran C, Celik C, Yuce K, Kucukali T. Ayhan A, et al. Int J Gynecol Cancer. 2002 Sep-Oct;12(5):448-53. doi: 10.1046/j.1525-1438.2002.t01-1-01133.x. Int J Gynecol Cancer. 2002. PMID: 12366661

9

The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma.

Ayhan A, Taskiran C, Yuce K, Kucukali T. Ayhan A, et al. Int J Gynecol Pathol. 2003 Jan;22(1):71-4. doi: 10.1097/00004347-200301000-00014. Int J Gynecol Pathol. 2003. PMID: 12496701

10

Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns.

Ayhan A, Taskiran C, Celik C, Aksu T, Yuce K. Ayhan A, et al. Eur J Gynaecol Oncol. 2002;23(6):553-6. Eur J Gynaecol Oncol. 2002. PMID: 12556104

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters